Leqembi and p-tau217: A Blood Test Offers a New Window Into Alzheimer’s
A personal look at what happened to my p-tau217 blood levels after starting Leqembi, and how new research suggests that changes in this Alzheimer’s biomarker may provide an early indication of how patients are responding to treatment.
How to Understand Your Alzheimer's Blood Tests and PET Scan Results
Alzheimer's lab reports can be confusing, filled with unfamiliar numbers and medical terms that leave many patients wondering what they actually mean. I felt the same way after my diagnosis. Over the course of my treatment, I learned how to understand my blood tests and amyloid PET scans, and that knowledge helped me follow my progress and ask better questions. This guide explains the key biomarkers and imaging results in plain English so you can better understand your own Alzheimer's test reports.